Alkermes plc (ALKS) vs. NeoGenomics, Inc. (NEO): Comparing the Biotechnology Industry's Most ...

ALKS's debt-to-equity ratio is 0.24 versus a D/E of 0.36 for NEO. NEO is therefore the more solvent of the two companies, and has lower financial risk.

from Source
December 26, 2018 at 07:33PM